Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer.
biomarkers
mutational profile
non-metastatic
precision medicine
rectal cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
25
10
2021
accepted:
08
12
2021
entrez:
24
1
2022
pubmed:
25
1
2022
medline:
25
1
2022
Statut:
epublish
Résumé
Rectal Cancer (RC) is a complex disease that involves highly variable treatment responses. Currently, there is a lack of reliable markers beyond TNM to deliver a personalized treatment in a cancer setting where the goal is a curative treatment. Here, we performed an integrated characterization of the predictive and prognostic role of clinical features, mismatch-repair deficiency markers, HER2, CDX2, PD-L1 expression, and CD3
Identifiants
pubmed: 35071006
doi: 10.3389/fonc.2021.801880
pmc: PMC8777220
doi:
Types de publication
Journal Article
Langues
eng
Pagination
801880Informations de copyright
Copyright © 2022 Iseas, Sendoya, Robbio, Coraglio, Kujaruk, Mikolaitis, Rizzolo, Cabanne, Ruiz, Salanova, Gualdrini, Méndez, Antelo, Carballido, Rotondaro, Viglino, Eleta, Di Sibio, Podhajcer, Roca, Llera, Golubicki and Abba.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancers (Basel). 2021 Mar 18;13(6):
pubmed: 33803620
Clin Cancer Res. 2018 Jan 1;24(1):224-233
pubmed: 29061646
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
PLoS One. 2014 May 06;9(5):e96801
pubmed: 24802416
Bull Cancer. 2019 Feb;106(2):119-128
pubmed: 30713006
Int J Mol Sci. 2017 Oct 24;18(10):
pubmed: 29064420
Eur J Cancer. 2018 Nov;103:205-213
pubmed: 30268921
Cancers (Basel). 2021 Mar 19;13(6):
pubmed: 33808549
J Clin Oncol. 2012 Jun 1;30(16):1926-33
pubmed: 22529255
J Clin Oncol. 2011 Oct 1;29(28):3753-60
pubmed: 21876084
Nat Rev Cancer. 2021 Aug;21(8):510-525
pubmed: 34244683
N Engl J Med. 2004 Oct 21;351(17):1731-40
pubmed: 15496622
World J Gastroenterol. 2015 May 7;21(17):5167-75
pubmed: 25954090
Colorectal Dis. 2016 Mar;18(3):234-46
pubmed: 26531759
Br J Cancer. 2018 Jul;119(1):40-51
pubmed: 29789606
World J Gastroenterol. 2015 Feb 7;21(5):1457-67
pubmed: 25663765
Colorectal Dis. 2015 Jun;17(6):491-8
pubmed: 25524450
J Clin Oncol. 2012 May 20;30(15):1770-6
pubmed: 22493423
Colorectal Dis. 2021 Sep;23(9):2473-2474
pubmed: 34157211
JAMA Oncol. 2018 Jun 14;4(6):e180071
pubmed: 29566109
Arch Pathol Lab Med. 2015 May;139(5):618-20
pubmed: 25275813
Cancer. 2008 Jul 1;113(1):57-64
pubmed: 18442099
Ann Coloproctol. 2021 Jun;37(3):179-185
pubmed: 33971705
J Clin Oncol. 2014 May 20;32(15):1554-62
pubmed: 24752056
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Clin Oncol. 2015 Jun 1;33(16):1797-808
pubmed: 25918296
Colorectal Dis. 2015 Oct;17(10):849-61
pubmed: 26260213
Nat Rev Cancer. 2016 Apr 26;16(5):319-29
pubmed: 27112209
Front Immunol. 2020 Aug 12;11:2039
pubmed: 32903444
Curr Colorectal Cancer Rep. 2015;11(5):275-280
pubmed: 26321890
Cancer Res. 2018 Jan 1;78(1):7-14
pubmed: 29263151
Oncoimmunology. 2015 Apr 02;4(3):e976052
pubmed: 25949894
Nat Rev Clin Oncol. 2016 Jun;13(6):361-9
pubmed: 26323388
Oncotarget. 2017 Dec 1;8(67):112103-112115
pubmed: 29340115
Dig Liver Dis. 2016 Nov;48(11):1372-1377
pubmed: 27260329
Lancet Oncol. 2010 Sep;11(9):835-44
pubmed: 20692872
World J Surg Oncol. 2020 Nov 30;18(1):313
pubmed: 33256819
Cancers (Basel). 2021 Sep 16;13(18):
pubmed: 34572869
Clin Cancer Res. 2019 Oct 1;25(19):5852-5858
pubmed: 31243121
J Clin Oncol. 2018 Mar 10;36(8):773-779
pubmed: 29355075
Int J Cancer. 2019 Jun 15;144(12):2992-3000
pubmed: 30536395
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Dis Colon Rectum. 2018 Aug;61(8):897-902
pubmed: 29771800
J Pers Med. 2020 Oct 16;10(4):
pubmed: 33081102
Ann Surg. 2020 Mar;271(3):440-448
pubmed: 31318794
Clin Cancer Res. 2019 Sep 15;25(18):5561-5571
pubmed: 31253631
Front Oncol. 2020 Aug 14;10:1369
pubmed: 32923389
Clin Cancer Res. 2020 Oct 1;26(19):5198-5207
pubmed: 32669377
Mod Pathol. 2017 Apr;30(4):599-609
pubmed: 27982025
J Gastrointest Cancer. 2022 Mar;53(1):151-160
pubmed: 33392960
N Engl J Med. 2016 Jun 2;374(22):2184
pubmed: 27248627
Ann Surg Oncol. 2016 Aug;23(8):2548-55
pubmed: 27020587
Ann Oncol. 2013 Dec;24(12):3123-8
pubmed: 24146218
EClinicalMedicine. 2019 Oct 24;16:4-5
pubmed: 31832607
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Cancers (Basel). 2020 Aug 10;12(8):
pubmed: 32784964
Oncotarget. 2017 Sep 21;8(49):86356-86368
pubmed: 29156800
PLoS One. 2015 Nov 06;10(11):e0142159
pubmed: 26544968
J Natl Cancer Inst. 2021 Nov 29;113(12):1683-1692
pubmed: 34405229
Nat Rev Cancer. 2018 Mar;18(3):139-147
pubmed: 29326431
Ann Surg Oncol. 2020 Oct;27(11):4319-4336
pubmed: 32524461
Clin Cancer Res. 2020 Jul 1;26(13):3271-3279
pubmed: 32144135
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Mod Pathol. 2004 Nov;17(11):1392-9
pubmed: 15205684
J Pathol Clin Res. 2014 Nov 05;1(1):3-17
pubmed: 27499889
Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40
pubmed: 28881920
Dis Colon Rectum. 2015 Jan;58(1):32-44
pubmed: 25489692